FDA Roundup: Soliris Biosimilar, Nonerosive GERD Treatment
Check out important updates from the FDA from over the past week.
Long-Term Oral Corticosteroid Use for AD Associated with Increased Risk of Adverse Events
The most common adverse events in patients using oral corticosteroids for more than 90 days included fracture, hyperlipidemia, myocardial infarction, and avascular necrosis.
Drug Advertising, Disease Awareness Misconstrue Patients’ Understanding of Pharmaceutical Benefits
Researchers aimed to determine the risks and benefits of prescription drug advertising released in tandem with disease awareness programming.
FDA Approval Marks Epysqli as Second Soliris Biosimilar
The approval of eculizumab-aagh offers more treatment options for patients with rare diseases PNH and aHUS.
NCPA Representative Discusses Role in Influencing PBM Reform
Steve Postal, JD, Director of Policy and Regulatory Affairs at the National Community Pharmacists Association (NCPA), sat down with Drug Topics to discuss Pharmacy Benefit Managers.
Weekend ICYMI: July 15 to July 19
In case you missed it, this week we had news about cybersecurity breaches at Rite Aid, advancements in chronic hand eczema treatment, the Superman Pharmacist, and more.
Now Trending: UnitedHealth Continues to Grow Revenue, Aspirin’s Association with CRC
Check out this recap of articles published on our sister sites during the past week.
Small Doses: July 15 to July 19
Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.
Chronic Hand Eczema Treatment Shows Positive Results in Phase 3 Trials
Delgocitinib cream from LEO Pharmaceuticals showed superior efficacy compared to cream vehicle and was well tolerated over 16 weeks.
Surescripts, DAW Systems Expands E-Prescribing to Veterinary Medicine
The collaboration between Surescripts and DAW Systems leverages Surescripts’ established e-prescribing network, which last year processed 2.5 billion prescriptions from 1.29 million prescribers across the US.
Q&A: What the NCPA is Doing to Fight Back Against PBMs
Steve Postal, JD, Director of Policy and Regulatory Affairs at the National Community Pharmacists Association (NCPA), discussed pharmacy benefit managers and vehicles necessary to induce reform.
Boehringer Ingelheim and GoodRx Partner to Offer Major Discount on Adalimumab-adbm
The initiative by Boehringer and GoodRx has the potential to accelerate the therapeutic timeline for patients treated with the biosimilar.
PBM Reform Law Aims to Support Local Pharmacies in Pennsylvania
House Bill (HB) 1993 seeks to increase PBM transparency and accountability in an effort to combat the rising cost of prescription drugs.
Intermittently Scanned CGM Can Reduce Hypoglycemic Episodes in T1D
Patients using isCGM had reduced glucose variability, time in low glucose range, time in very low glucose range, and less events related to low glucose levels.
Man of Heal: The Story of the Superman Pharmacist
In part 2 of the latest episode of Over the Counter, Mayank Amin, PharmD, RPh, MBA, discusses his journey as the Superman Pharmacist and expresses hope for the future of community pharmacy.
The Girls Are Back: One Pharmacist’s Journey to Save His Community Pharmacy
Mayank Amin, PharmD, RPh, MBA, sat down with Drug Topics on part 1 of an episode of Over the Counter to share his experiences transforming a shuttered independent pharmacy into a thriving community hub.
Emporos, InterLink AI Partnership to Revolutionize POS in the Pharmacy
Emporos announced a strategic partnership with InterLink AI to help pharmacists streamline tasks and fill more prescriptions.
Long COVID Risk Reduced by 70% Following Vaccination
“If people think COVID is no big deal and decide to forgo vaccinations, they’re essentially doubling their risk of developing long COVID,” wrote investigators.
Rite Aid Addresses Cyberattack: 2.2 Million Customers’ Data Breached
The retail pharmacy chain issued an alert to its customers that purchasing data from 2017 to 2018 may have been breached by a third party.
Children with T1D at Increased Risk of Psychiatric Disorders Later in Life
Patients with childhood type 1 diabetes were more likely to develop substance use disorders, mood disorders, anxiety disorders, and behavioral syndromes.
Bird Flu Virus Spreads in Dairy Cattle, But Human Health Risk Remains Low
The CDC issued a report on the state of the avian influenza, or bird flu, at the end of last week.
How Pharmacies Should Prepare as the DSCSA Stabilization Period Ends
As the end of the DSCSA stabilization period approaches, Scott Mooney, vice president of distribution operations at McKesson, discussed what pharmacists should consider to be prepared.
COVID-19 Infection Associated with Long-Term Impact on Immune System
COVID-19 patients had reduced absolute granulocyte, monocyte, and lymphocyte counts at 10 months post-infection compared to noninfected individuals.
McKesson ideaShare 2024 Recap
Look back at some of the amazing insights during McKesson ideaShare, the premier event for community pharmacists.
Medication, Health Care Affordability Improved During COVID-19 Pandemic
Researchers compared health care and prescription medication affordability during the COVID-19 pandemic to pre-pandemic numbers.
Overcoming PTSD: Farron Dozier Discusses His Experience in the US Army
Farron Dozier, former sergeant first class in the US Army, sat down with Drug Topics on a recent episode of Over the Counter to discuss his experience with PTSD.
Weekend ICYMI: July 8 to July 12
In case you missed it, this week we had news about FTC-backed PBM investigations, FDA approvals in atopic dermatitis, misconceptions about dry eye, and more.
Now Trending: The Downfall of Retail Health Care, FTC Reports on PBMs
Small Doses: July 8 to July 12
Stigmatization Plays Key Role in the Mental Health of Children with Skin Disease
Researchers aimed to address the extent of stigmatization’s effect on the mental health of adolescents with chronic skin disorders.
